Tarek Sahmoud
Keine laufenden Positionen mehr
Karriereverlauf von Tarek Sahmoud
Ehemalige bekannte Positionen von Tarek Sahmoud
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CONTEXT THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - | 31.12.2023 |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2016 | 01.07.2017 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| HUMANIGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2018 | - |
Ausbildung von Tarek Sahmoud
| KasrAlAiny School of Medicine | Undergraduate Degree |
| Bordeaux Segalen University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Ägypten | 2 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Börse
- Insiders
- Tarek Sahmoud
- Erfahrung
